Top Markets
#1 Black Phoenix Black Phoenix +365.41%
#2 Islamic Coin Islamic Coin +158.18%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.15%
#5 Akedo Akedo +35.88%
#6 Acurast Acurast +28.33%
#7 BasedHype BasedHype +27.99%
#8 Cryptopia Cryptopia +21.42%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.34%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +20.60%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Neuropathix, Inc. Neuropathix, Inc.

Neuropathix, Inc.

NPTX
Clasificación en acciones #41304
Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying,... Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying, advancing, and bringing to market innovative treatments derived from its exclusive platform of synthetic cannabinoid derivatives. The company's efforts are concentrated on the research and preclinical development of chemical compounds like KLS-13019, KLS-13023, and KLS-13022, alongside associated molecules and synthetic cannabidiol-based therapies. These investigational drugs are being explored for their potential application in treating various conditions, including chemotherapy-induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. Previously operating as Kannalife, Inc., the organization rebranded as Neuropathix, Inc. in November 2020. Established in 2010, Neuropathix, Inc. maintains its headquarters in Doylestown, Pennsylvania.
Precio por acción
$0.0003
Última sincronización: 2023-06-13
Capitalización bursátil
$28.14K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Neuropathix, Inc. (NPTX)

Categoría

Healthcare
Ratio P/B de Neuropathix, Inc. (NPTX)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Neuropathix, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Neuropathix, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE